Wang, Qin

Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA

Kettunen, J., Demirkan, A., Würtz, P., Draisma, H. H. M., Haller, T., Rawal, R., Vaarhorst, A., Kangas, A. J., Lyytikäinen, L.-P., Pirinen, M., et al. (2016) · Nature Communications

Genetic Associations and EpidemiologyMetabolomics and Mass Spectrometry Studies

Cited by 738

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Folkersen, L., Gustafsson, S., Wang, Q., Hansen, D. H., Hedman, Å. K., Schork, A., Page, K., Zhernakova, D. V., Wu, Y., Peters, J., et al. (2020) · Nature Metabolism

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 705

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation

Richardson, T. G., Leyden, G. M., Wang, Q., Bell, J. A., Elsworth, B., Davey Smith, G., & Holmes, M. V. (2022) · PLOS Biology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 304

Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change

Würtz, P., Wang, Q., Kangas, A. J., Richmond, R. C., Skarp, J., Tiainen, M., Tynkkynen, T., Soininen, P., Havulinna, A. S., Kaakinen, M., et al. (2014) · PLoS Medicine

Adipokines, Inflammation, and Metabolic DiseasesMetabolomics and Mass Spectrometry Studies

Cited by 280

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase

Würtz, P., Wang, Q., Soininen, P., Kangas, A. J., Fatemifar, G., Tynkkynen, T., Tiainen, M., Perola, M., Tillin, T., Hughes, A. D., et al. (2016) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthMetabolomics and Mass Spectrometry Studies

Cited by 188

Metabolic characterization of menopause: cross-sectional and longitudinal evidence

Wang, Q., Ferreira, D. L. S., Nelson, S. M., Sattar, N., Ala-Korpela, M., & Lawlor, D. A. (2018) · BMC Medicine

Menopause: Health Impacts and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 134

Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence

Wang, Q., Würtz, P., Auro, K., Morin-Papunen, L., Kangas, A. J., Soininen, P., Tiainen, M., Tynkkynen, T., Joensuu, A., Havulinna, A. S., et al. (2016) · International Journal of Epidemiology

Reproductive Health and ContraceptionMetabolomics and Mass Spectrometry Studies

Cited by 117

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment

Sliz, E., Kettunen, J., Holmes, M. V., Williams, C. O., Boachie, C., Wang, Q., Männikkö, M., Sebert, S., Walters, R., Lin, K., et al. (2018) · Circulation

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 109

Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis

Wang, Q., Oliver-Williams, C., Raitakari, O. T., Viikari, J., Lehtimäki, T., Kähönen, M., Järvelin, M.-R., Salomaa, V., Perola, M., Danesh, J., et al. (2021) · European Heart Journal

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 89

Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition

Kettunen, J., Holmes, M. V., Allara, E., Anufrieva, O., Ohukainen, P., Oliver-Williams, C., Wang, Q., Tillin, T., Hughes, A. D., Kähönen, M., et al. (2019) · PLOS Biology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 47

Short-term systolic blood pressure variability and kidney disease progression in patients with chronic kidney disease: results from C-STRIDE

Wang, Q., Wang, Y., Wang, J., Zhang, L., Zhao, M., Wang, X., Yuan, J., Zhou, Q., Yuan, Q., Chen, M., et al. (2020) · Journal of the American Heart Association

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 24